Similarly, tumor-derived NY-ESO-192–100 CD8+ T cells isolated from ovarian cancer patients showed an upregulation of the inhibitory molecules PD-1 and LAG-3 with dual blockade enhancing the proliferation and cytokine production (145). This evidence concerns the gene CD8A and ovarian carcinoma.